Deutsche Bank AG Purchases Shares of 379,908 Sotera Health Company $SHC

Key Points

• Deutsche Bank acquired 379,908 Sotera Health shares worth approximately $6.7 million during the second quarter, while institutional investors collectively own 91.03% of the company.
• Analysts remain broadly positive, with eight Buy ratings and three Holds producing a “Moderate Buy” consensus and an average price target of $21.50.
• Sotera Health exceeded quarterly expectations, reporting $0.26 in EPS and $321.38 million in revenue, up 9.2% year over year; however, insiders sold approximately 1.29 million shares worth $24 million over the past 90 days.

Deutsche Bank AG purchased a new position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 379,908 shares of the company's stock, valued at approximately $6,743,000. Deutsche Bank AG owned 0.13% of Sotera Health as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Sculptor Capital LP grew its stake in shares of Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company's stock valued at $370,440,000 after buying an additional 7,658,200 shares during the period. Sachem Head Capital Management LP grew its position in Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company's stock valued at $205,418,000 after acquiring an additional 3,735,000 shares during the period. Vanguard Group Inc. increased its stake in Sotera Health by 16.7% during the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company's stock worth $339,189,000 after acquiring an additional 2,756,583 shares during the last quarter. AQR Capital Management LLC increased its stake in Sotera Health by 1,206.2% during the fourth quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company's stock worth $50,523,000 after acquiring an additional 2,644,831 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Sotera Health in the 4th quarter worth about $45,278,000. Institutional investors and hedge funds own 91.03% of the company's stock.

Analysts Set New Price Targets

SHC has been the subject of several research reports. Weiss Ratings upgraded shares of Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Barclays raised their target price on shares of Sotera Health from $19.00 to $22.00 and gave the company an "overweight" rating in a research note on Friday, August 7th. JPMorgan Chase & Co. lifted their target price on shares of Sotera Health from $16.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, August 7th. UBS Group set a $19.00 price target on shares of Sotera Health in a research report on Wednesday, June 24th. Finally, The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, June 5th. They issued a "buy" rating and a $20.00 price target for the company. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Sotera Health presently has a consensus rating of "Moderate Buy" and an average target price of $21.50.

Sotera Health Stock Down 2.0%

Shares of NASDAQ:SHC opened at $19.17 on Tuesday. The firm has a market cap of $5.47 billion, a PE ratio of 33.63 and a beta of 1.77. The company has a fifty day simple moving average of $17.82 and a 200 day simple moving average of $16.35. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. Sotera Health Company has a 12-month low of $13.09 and a 12-month high of $19.85.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. The business had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The company's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities research analysts anticipate that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares of the company's stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 1,294,515 shares of company stock valued at $23,999,528. 15.36% of the stock is currently owned by insiders.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source